• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SOM 0.00% 29.0¢

SOMNOMED LIMITED - Announcements

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling... SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
SOM Trading updatePRICE SENSITIVE25/03/19
SOM S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
SOM Investor PresentationPRICE SENSITIVE21/02/19
SOM Half Yearly Report and AccountsPRICE SENSITIVE21/02/19
SOM Core revenue growth up 13% in Q2PRICE SENSITIVE29/01/19
SOM Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
SOM 2018 AGM addresses - Chairman and CEOPRICE SENSITIVE27/11/18
SOM Change in Leadership of SomnoMedPRICE SENSITIVE19/11/18
SOM Response to Appendix 4C QueryPRICE SENSITIVE05/11/18
SOM Strong first quarter in Core business diluted by RSS resultsPRICE SENSITIVE26/10/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/10/18
SOM Investor presentationPRICE SENSITIVE22/08/18
SOM Full year results and the consolidation of RSS operationsPRICE SENSITIVE22/08/18
SOM Preliminary Final ReportPRICE SENSITIVE22/08/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE25/07/18 download Created with Sketch. 346.95KB
SOM SomnoMed posts 30% revenue growth for FY2018PRICE SENSITIVE25/07/18 download Created with Sketch. 193.01KB
SOM Trading UpdatePRICE SENSITIVE24/05/18 download Created with Sketch. 255.27KB
SOM Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
SOM Results of Retail Entitlement OfferPRICE SENSITIVE19/03/18
SOM Retail Entitlement Offer Information BookletPRICE SENSITIVE21/02/18
SOM Successful completion of Institutional Entitlement OfferPRICE SENSITIVE21/02/18
SOM Half Year AccountsPRICE SENSITIVE19/02/18
SOM Accelerated non-renounceable entitlement offerPRICE SENSITIVE19/02/18
SOM ASX Market Release - Trading HaltPRICE SENSITIVE19/02/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE24/01/18
SOM Revenue growth up 45% in Q2PRICE SENSITIVE24/01/18
SOM Good revenue growth for the quarterPRICE SENSITIVE26/10/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/10/17
SOM Investor PresentationPRICE SENSITIVE24/08/17
SOM Preliminary Final ReportPRICE SENSITIVE24/08/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE24/07/17
SOM Strong Q4 growth to finish transitional yearPRICE SENSITIVE24/07/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/04/17
SOM Renew Sleep Solutions well ahead of planPRICE SENSITIVE26/04/17
SOM Half Year AccountsPRICE SENSITIVE23/02/17
SOM Renew Sleep Solutions opens first two centres in Q2PRICE SENSITIVE23/01/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE23/01/17
SOM Appendix 4C - quarterly-SOM.AX PRICE SENSITIVE18/10/16
SOM Sales growth accelerating-SOM.AX PRICE SENSITIVE18/10/16
SOM FDA 510k approval for SomnoDent Alpha-SOM.AX PRICE SENSITIVE21/09/16
SOM Preliminary Final Report-SOM.AX PRICE SENSITIVE18/08/16
SOM Appendix 4C - quarterly-SOM.AX PRICE SENSITIVE21/07/16
SOM Strong finish to the financial year for SomnoMed-SOM.AX PRICE SENSITIVE21/07/16
SOM Derek Smith appointed Global CEO of SomnoMed-SOM.AX PRICE SENSITIVE19/07/16
SOM Retail Entitlement Offer Information Booklet-SOM.AX PRICE SENSITIVE05/05/16
SOM Results of Institutional Entitlement Offer-SOM.AX PRICE SENSITIVE05/05/16
SOM Accelerated non-renounceable entitlement offer-SOM.AX PRICE SENSITIVE03/05/16
SOM Chairman's Letter-SOM.AX PRICE SENSITIVE03/05/16
SOM Trading Halt-SOM.AX PRICE SENSITIVE03/05/16
SOM Continuing High Growth in the Third Quarter-SOM.AX PRICE SENSITIVE20/04/16
SOM Appendix 4C - quarterly-SOM.AX PRICE SENSITIVE20/04/16
SOM Half Yearly Report and AccountsPRICE SENSITIVE18/02/16
SOM Appendix 4C - quarterlyPRICE SENSITIVE19/01/16
SOM 30% growth of direct sales revenues of Somnodent devicesPRICE SENSITIVE19/01/16
SOM SomnoMed exceeds 250,000 patientsPRICE SENSITIVE22/10/15
SOM Appendix 4C - quarterlyPRICE SENSITIVE13/10/15
SOM Growth acceleration in the US leads to new record quarterPRICE SENSITIVE13/10/15
SOM Preliminary Final ReportPRICE SENSITIVE20/08/15
SOM Appendix 4C - quarterlyPRICE SENSITIVE15/07/15
SOM Strong finish to the financial year for SomnoMedPRICE SENSITIVE15/07/15
SOM FDA approves SomnoDent wearable compliance micro-recordingPRICE SENSITIVE22/06/15
SOM SomnoMed to acquire 100% of SMH Biomaterial AGPRICE SENSITIVE25/05/15
SOM SomnoMed updatePRICE SENSITIVE20/05/15
SOM Appendix 4C - quarterlyPRICE SENSITIVE10/04/15
SOM Continuous growth of SomnoMed in third quarterPRICE SENSITIVE10/04/15
MPL +S&P DJ Indices Announces March Quarterly ReviewPRICE SENSITIVE06/03/15
SOM Half Yearly Report and AccountsPRICE SENSITIVE18/02/15
SOM Appendix 4C - quarterlyPRICE SENSITIVE28/01/15
SOM SomnoMed exceeds 200,000 patientsPRICE SENSITIVE10/11/14
SOM Appendix 4C - quarterlyPRICE SENSITIVE16/10/14
SOM New records in September confirm guidancePRICE SENSITIVE16/10/14
SOM Preliminary Final ReportPRICE SENSITIVE21/08/14
SOM Share Purchase Plan Offer and RulesPRICE SENSITIVE30/07/14
SOM Share Placement and 2014 Share Purchase PlanPRICE SENSITIVE25/07/14
SOM Trading HaltPRICE SENSITIVE24/07/14
SOM Appendix 4C - quarterlyPRICE SENSITIVE23/07/14
SOM New sales records in Q4 & increasing growth prospects14/15PRICE SENSITIVE23/07/14
SOM SomnoMed takes over Italian DistributionPRICE SENSITIVE10/07/14
SOM SomnoMed USA receives 510K for Somnodent FusionPRICE SENSITIVE24/06/14
SOMSomnoMed starts business in Spain and PortugalPRICE SENSITIVE26/05/14
SOMSomnoMed enters UK - Ireland marketPRICE SENSITIVE16/05/14
SOMSomnoMed commences business in FinlandPRICE SENSITIVE01/05/14
SOMAppendix 4C - quarterlyPRICE SENSITIVE10/04/14
SOMSomnoMed achieves 28% volume growth in Q3PRICE SENSITIVE10/04/14
SOMHalf Yearly Report and AccountsPRICE SENSITIVE26/02/14
SOMAppendix 4C - quarterlyPRICE SENSITIVE16/01/14
SOMSomnoMed accelerates growth in Q2PRICE SENSITIVE16/01/14
SOMSomnoMed exceeds 150,000 patients wordwidePRICE SENSITIVE21/11/13
SOMAppendix 4C - quarterlyPRICE SENSITIVE25/10/13
SOMSomnoMed expands in KoreaPRICE SENSITIVE17/10/13
SOMPreliminary Final ReportPRICE SENSITIVE27/08/13
SOMAppendix 4C - quarterlyPRICE SENSITIVE19/07/13
SOMSomnoMed posts strong cash positionPRICE SENSITIVE19/07/13
SOMSomnoMed acquires Orthosleep19 in GermanyPRICE SENSITIVE04/07/13
SOMSomnoMed breaks through 10,000 unit sales in 4th QuarterPRICE SENSITIVE02/07/13
SOMProgress in USAPRICE SENSITIVE12/06/13
SOMAppendix 4C - quarterlyPRICE SENSITIVE12/04/13
SOMStrong European growth and new US management team in placePRICE SENSITIVE12/04/13
SOMHalf Yearly Report and AccountsPRICE SENSITIVE26/02/13
SOMAppendix 4C - quarterlyPRICE SENSITIVE30/01/13
SOM Trading update
25/03/19PRICE SENSITIVE
SOM S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
SOM Investor Presentation
21/02/19PRICE SENSITIVE
SOM Half Yearly Report and Accounts
21/02/19PRICE SENSITIVE
SOM Core revenue growth up 13% in Q2
29/01/19PRICE SENSITIVE
SOM Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
SOM 2018 AGM addresses - Chairman and CEO
27/11/18PRICE SENSITIVE
SOM Change in Leadership of SomnoMed
19/11/18PRICE SENSITIVE
SOM Response to Appendix 4C Query
05/11/18PRICE SENSITIVE
SOM Strong first quarter in Core business diluted by RSS results
26/10/18PRICE SENSITIVE
SOM Appendix 4C - quarterly
26/10/18PRICE SENSITIVE
SOM Investor presentation
22/08/18PRICE SENSITIVE
SOM Full year results and the consolidation of RSS operations
22/08/18PRICE SENSITIVE
SOM Preliminary Final Report
22/08/18PRICE SENSITIVE
SOM Appendix 4C - quarterly
25/07/18PRICE SENSITIVE download Created with Sketch. 346.95KB
SOM SomnoMed posts 30% revenue growth for FY2018
25/07/18PRICE SENSITIVE download Created with Sketch. 193.01KB
SOM Trading Update
24/05/18PRICE SENSITIVE download Created with Sketch. 255.27KB
SOM Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
SOM Results of Retail Entitlement Offer
19/03/18PRICE SENSITIVE
SOM Retail Entitlement Offer Information Booklet
21/02/18PRICE SENSITIVE
SOM Successful completion of Institutional Entitlement Offer
21/02/18PRICE SENSITIVE
SOM Half Year Accounts
19/02/18PRICE SENSITIVE
SOM Accelerated non-renounceable entitlement offer
19/02/18PRICE SENSITIVE
SOM ASX Market Release - Trading Halt
19/02/18PRICE SENSITIVE
SOM Appendix 4C - quarterly
24/01/18PRICE SENSITIVE
SOM Revenue growth up 45% in Q2
24/01/18PRICE SENSITIVE
SOM Good revenue growth for the quarter
26/10/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
26/10/17PRICE SENSITIVE
SOM Investor Presentation
24/08/17PRICE SENSITIVE
SOM Preliminary Final Report
24/08/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
24/07/17PRICE SENSITIVE
SOM Strong Q4 growth to finish transitional year
24/07/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
26/04/17PRICE SENSITIVE
SOM Renew Sleep Solutions well ahead of plan
26/04/17PRICE SENSITIVE
SOM Half Year Accounts
23/02/17PRICE SENSITIVE
SOM Renew Sleep Solutions opens first two centres in Q2
23/01/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
23/01/17PRICE SENSITIVE
SOM Appendix 4C - quarterly-SOM.AX
18/10/16PRICE SENSITIVE
SOM Sales growth accelerating-SOM.AX
18/10/16PRICE SENSITIVE
SOM FDA 510k approval for SomnoDent Alpha-SOM.AX
21/09/16PRICE SENSITIVE
SOM Preliminary Final Report-SOM.AX
18/08/16PRICE SENSITIVE
SOM Appendix 4C - quarterly-SOM.AX
21/07/16PRICE SENSITIVE
SOM Strong finish to the financial year for SomnoMed-SOM.AX
21/07/16PRICE SENSITIVE
SOM Derek Smith appointed Global CEO of SomnoMed-SOM.AX
19/07/16PRICE SENSITIVE
SOM Retail Entitlement Offer Information Booklet-SOM.AX
05/05/16PRICE SENSITIVE
SOM Results of Institutional Entitlement Offer-SOM.AX
05/05/16PRICE SENSITIVE
SOM Accelerated non-renounceable entitlement offer-SOM.AX
03/05/16PRICE SENSITIVE
SOM Chairman's Letter-SOM.AX
03/05/16PRICE SENSITIVE
SOM Trading Halt-SOM.AX
03/05/16PRICE SENSITIVE
SOM Continuing High Growth in the Third Quarter-SOM.AX
20/04/16PRICE SENSITIVE
SOM Appendix 4C - quarterly-SOM.AX
20/04/16PRICE SENSITIVE
SOM Half Yearly Report and Accounts
18/02/16PRICE SENSITIVE
SOM Appendix 4C - quarterly
19/01/16PRICE SENSITIVE
SOM 30% growth of direct sales revenues of Somnodent devices
19/01/16PRICE SENSITIVE
SOM SomnoMed exceeds 250,000 patients
22/10/15PRICE SENSITIVE
SOM Appendix 4C - quarterly
13/10/15PRICE SENSITIVE
SOM Growth acceleration in the US leads to new record quarter
13/10/15PRICE SENSITIVE
SOM Preliminary Final Report
20/08/15PRICE SENSITIVE
SOM Appendix 4C - quarterly
15/07/15PRICE SENSITIVE
SOM Strong finish to the financial year for SomnoMed
15/07/15PRICE SENSITIVE
SOM FDA approves SomnoDent wearable compliance micro-recording
22/06/15PRICE SENSITIVE
SOM SomnoMed to acquire 100% of SMH Biomaterial AG
25/05/15PRICE SENSITIVE
SOM SomnoMed update
20/05/15PRICE SENSITIVE
SOM Appendix 4C - quarterly
10/04/15PRICE SENSITIVE
SOM Continuous growth of SomnoMed in third quarter
10/04/15PRICE SENSITIVE
MPL +S&P DJ Indices Announces March Quarterly Review
06/03/15PRICE SENSITIVE
SOM Half Yearly Report and Accounts
18/02/15PRICE SENSITIVE
SOM Appendix 4C - quarterly
28/01/15PRICE SENSITIVE
SOM SomnoMed exceeds 200,000 patients
10/11/14PRICE SENSITIVE
SOM Appendix 4C - quarterly
16/10/14PRICE SENSITIVE
SOM New records in September confirm guidance
16/10/14PRICE SENSITIVE
SOM Preliminary Final Report
21/08/14PRICE SENSITIVE
SOM Share Purchase Plan Offer and Rules
30/07/14PRICE SENSITIVE
SOM Share Placement and 2014 Share Purchase Plan
25/07/14PRICE SENSITIVE
SOM Trading Halt
24/07/14PRICE SENSITIVE
SOM Appendix 4C - quarterly
23/07/14PRICE SENSITIVE
SOM New sales records in Q4 & increasing growth prospects14/15
23/07/14PRICE SENSITIVE
SOM SomnoMed takes over Italian Distribution
10/07/14PRICE SENSITIVE
SOM SomnoMed USA receives 510K for Somnodent Fusion
24/06/14PRICE SENSITIVE
SOMSomnoMed starts business in Spain and Portugal
26/05/14PRICE SENSITIVE
SOMSomnoMed enters UK - Ireland market
16/05/14PRICE SENSITIVE
SOMSomnoMed commences business in Finland
01/05/14PRICE SENSITIVE
SOMAppendix 4C - quarterly
10/04/14PRICE SENSITIVE
SOMSomnoMed achieves 28% volume growth in Q3
10/04/14PRICE SENSITIVE
SOMHalf Yearly Report and Accounts
26/02/14PRICE SENSITIVE
SOMAppendix 4C - quarterly
16/01/14PRICE SENSITIVE
SOMSomnoMed accelerates growth in Q2
16/01/14PRICE SENSITIVE
SOMSomnoMed exceeds 150,000 patients wordwide
21/11/13PRICE SENSITIVE
SOMAppendix 4C - quarterly
25/10/13PRICE SENSITIVE
SOMSomnoMed expands in Korea
17/10/13PRICE SENSITIVE
SOMPreliminary Final Report
27/08/13PRICE SENSITIVE
SOMAppendix 4C - quarterly
19/07/13PRICE SENSITIVE
SOMSomnoMed posts strong cash position
19/07/13PRICE SENSITIVE
SOMSomnoMed acquires Orthosleep19 in Germany
04/07/13PRICE SENSITIVE
SOMSomnoMed breaks through 10,000 unit sales in 4th Quarter
02/07/13PRICE SENSITIVE
SOMProgress in USA
12/06/13PRICE SENSITIVE
SOMAppendix 4C - quarterly
12/04/13PRICE SENSITIVE
SOMStrong European growth and new US management team in place
12/04/13PRICE SENSITIVE
SOMHalf Yearly Report and Accounts
26/02/13PRICE SENSITIVE
SOMAppendix 4C - quarterly
30/01/13PRICE SENSITIVE
(20min delay)
Last
29.0¢
Change
0.000(0.00%)
Mkt cap ! $95.08M
Open High Low Value Volume
29.0¢ 29.5¢ 29.0¢ $7.157K 24.43K

Buyers (Bids)

No. Vol. Price($)
1 10000 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 3200 1
View Market Depth
Last trade - 10.37am 15/11/2024 (20 minute delay) ?
Last
29.0¢
  Change
0.000 ( 1.75 %)
Open High Low Volume
28.5¢ 29.0¢ 28.5¢ 6638
Last updated 10.19am 15/11/2024 ?
SOM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.